Form D · Other Technology
Unite Genomics, Inc.
San Mateo, CA · CIK 0001760629
Offering snapshot reported Nov 21, 2023 · SEC filing
- Reported sold
- $2M Offering amount: $2M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $35K Reported outside-investor minimum
- First sale
- Oct 11, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 21, 2023 | Initial | $2,000,905 | No comparison | 4 | SEC filing |
| Dec 6, 2018 | Initial | $5,782,499 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-497772
Source: Form D, filed Nov 21, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Taner Dagdelen | Director, Executive |
| Anthony Joseph | Director, Executive |
| Pete Sonsini | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
3 East Third Street, Suite 200 #105
San Mateo, CA, 94401
San Mateo, CA, 94401